{
    "filename": "1751-2980.12851.pdf",
    "content_type": "application/pdf",
    "file_size": 0,
    "metadata": {
        "identifiers": {
            "doi": "10.1111/1751-2980.12851",
            "url": "https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/1751-2980.12851"
        },
        "title": "2019 Novel coronavirus infection and gastrointestinal tract",
        "date": 2020,
        "author": "Qin Yan Gao, Ying Xuan Chen, Jing Yuan Fang",
        "affiliations": [
            "Division of Gastroenterology and HepatologyKey Laboratory of Gastroenterology &amp; Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China",
            "Division of Gastroenterology and HepatologyKey Laboratory of Gastroenterology &amp; Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China",
            "Division of Gastroenterology and HepatologyKey Laboratory of Gastroenterology &amp; Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University Shanghai China"
        ],
        "journal": "Journal of Digestive Diseases",
        "abstract": "Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality. And COVID-19 is the seventh. Phylogenetic analysis of the complete viral genome (29 903 nucleotides) has shown that the COVID-19 is most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses.[<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>] This fact could partly explain the behavior of this novel coronavirus in human infection.",
        "references": "@misc{wu-a,\n  author = {Wu, F. and Zhao, S. and Yu, B.},\n  title = {A new coronavirus associated with human respiratory disease in China [published online ahead of print February 3, 2020]. Nature},\n  url = {https://doi.org/10.1038/s41586-0202008-3.},\n  more-authors = {true},\n  language = {}\n}\n@article{chen-a,\n  author = {Chen, N. and Zhou, M. and Dong, X.},\n  title = {Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study},\n  journal = {Lancet},\n  volume = {2020},\n  pages = {507\u2013513},\n  more-authors = {true},\n  number = {395},\n  language = {}\n}\n@incollection{wang-a,\n  author = {Wang, D. and Hu, B. and Hu, C.},\n  title = {Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China},\n  booktitle = {[published online ahead of print},\n  date = {February 7,},\n  pages = {2020},\n  publisher = {JAMA},\n  url = {https://doi.org/10.1001/jama.2020.1585.},\n  more-authors = {true},\n  language = {}\n}\n@article{zhang-a,\n  author = {Zhang, W. and Du, R.H. and Li, B.},\n  title = {Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes},\n  journal = {Emerg Microbes Infect},\n  volume = {2020},\n  pages = {386\u2013389},\n  more-authors = {true},\n  number = {9},\n  language = {}\n}\n@article{lu-a,\n  author = {Lu, R. and Zhao, X. and Li, J.},\n  title = {Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding},\n  journal = {Lancet},\n  volume = {2020},\n  pages = {565\u2013574},\n  more-authors = {true},\n  number = {395},\n  language = {}\n}\n@misc{chai-a,\n  author = {Chai, Z. and Hu, L. and Zhang, Y.},\n  title = {Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection},\n  note = {Epub on www.biorxiv.org February 04, 2020},\n  url = {https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1},\n  more-authors = {true},\n  language = {}\n}\n@article{hashimoto2012a,\n  author = {Hashimoto, T. and Perlot, T. and Rehman, A.},\n  title = {ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation},\n  journal = {Nature},\n  date = {2012},\n  volume = {487},\n  pages = {477\u2013481},\n  more-authors = {true},\n  number = {7408},\n  language = {}\n}\n@article{bradley2019a,\n  author = {Bradley, K.C. and Finsterbusch, K. and Schnepf, D.},\n  title = {Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection},\n  journal = {Cell Rep},\n  date = {2019},\n  volume = {28},\n  pages = {245\u2013256},\n  more-authors = {true},\n  number = {1},\n  language = {}\n}\n@book{unknown-a,\n  title = {the People's Republic of China, National Administration of Traditional Chinese Medicine. Diagnostic and therapeutic guidance for 2019 novel coronavirus},\n  publisher = {disease (version},\n  date = {5).},\n  url = {http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf},\n  language = {},\n  organization = {National Health Committee of}\n}\n",
        "links": [
            "https://orcid.org/0000-0003-2282-0248",
            "https://orcid.org/0000-0002-1883-7736",
            "https://orcid.org/0000-0001-9422-300X"
        ],
        "emails": [
            "jingyuanfang@sjtu.edu.cn"
        ],
        "references_ris": "TY  - GEN\nAU  - Wu, F.\nAU  - Zhao, S.\nAU  - Yu, B.\nTI  - A new coronavirus associated with human respiratory disease in China [published online ahead of print February 3, 2020]. Nature\nUR  - https://doi.org/10.1038/s41586-0202008-3.\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Chen, N.\nAU  - Zhou, M.\nAU  - Dong, X.\nTI  - Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study\nT2  - Lancet\nVL  - 2020\nSP  - 507\nEP  - 513\nC1  - true\nIS  - 395\nLA  - \nER  - \n\nTY  - CHAP\nAU  - Wang, D.\nAU  - Hu, B.\nAU  - Hu, C.\nTI  - Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China\nT2  - [published online ahead of print\nPY  - February 7,\nDA  - February 7,\nSP  - 2020\nPB  - JAMA\nUR  - https://doi.org/10.1001/jama.2020.1585.\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Zhang, W.\nAU  - Du, R.H.\nAU  - Li, B.\nTI  - Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes\nT2  - Emerg Microbes Infect\nVL  - 2020\nSP  - 386\nEP  - 389\nC1  - true\nIS  - 9\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Lu, R.\nAU  - Zhao, X.\nAU  - Li, J.\nTI  - Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding\nT2  - Lancet\nVL  - 2020\nSP  - 565\nEP  - 574\nC1  - true\nIS  - 395\nLA  - \nER  - \n\nTY  - GEN\nAU  - Chai, Z.\nAU  - Hu, L.\nAU  - Zhang, Y.\nTI  - Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection\nN1  - Epub on www.biorxiv.org February 04, 2020\nUR  - https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1\nC1  - true\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Hashimoto, T.\nAU  - Perlot, T.\nAU  - Rehman, A.\nTI  - ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation\nT2  - Nature\nPY  - 2012\nDA  - 2012\nVL  - 487\nSP  - 477\nEP  - 481\nC1  - true\nIS  - 7408\nLA  - \nER  - \n\nTY  - JOUR\nAU  - Bradley, K.C.\nAU  - Finsterbusch, K.\nAU  - Schnepf, D.\nTI  - Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection\nT2  - Cell Rep\nPY  - 2019\nDA  - 2019\nVL  - 28\nSP  - 245\nEP  - 256\nC1  - true\nIS  - 1\nLA  - \nER  - \n\nTY  - BOOK\nTI  - the People's Republic of China, National Administration of Traditional Chinese Medicine. Diagnostic and therapeutic guidance for 2019 novel coronavirus\nPB  - disease (version\nPY  - 5).\nDA  - 5).\nUR  - http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf\nLA  - \nC1  - National Health Committee of\nER  - \n\n",
        "author_conclusions": [],
        "table_captions": [],
        "figure_captions": []
    },
    "sections": {
        "disclosures": [
            "<strong>CONFLICT OF INTEREST None</strong><br/><br/>Qin Yan Gao Ying Xuan Chen Jing Yuan Fang<br/><br/>Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China<br/><br/>Correspondence Jing Yuan Fang, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Middle Shandong Road, Shanghai<br/><br/>ORCID Qin Yan Gao https://orcid.org/0000-0001-9422-300X Ying Xuan Chen https://orcid.org/0000-0002-1883-7736 Jing Yuan Fang https://orcid.org/0000-0003-2282-0248"
        ],
        "introduction": [
            "Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality. And COVID-19 is the seventh. Phylogenetic analysis of the complete viral genome (29 903 nucleotides) has shown that the COVID-19 is most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses.[<a class=\"ref-link\" id=\"c1\" href=\"#r1\">1</a>] This fact could partly explain the behavior of this novel coronavirus in human infection.",
            "Retrospective studies from Wuhan, China have indicated that the main clinical manifestations of COVID-19 are fever, cough and dyspnea. Less common symptoms include the production of sputum, headache, hemoptysis and some gastrointestinal symptoms. It seems that gastrointestinal symptoms, such as diarrhea (2%-10.1%), and nausea and vomiting (1%-3.6%), are not very common at present.[<a class=\"ref-link\" id=\"c2\" href=\"#r2\">2</a>,<a class=\"ref-link\" id=\"c3\" href=\"#r3\">3</a>] However, a significant proportion of patients presented initially with those atypical gastrointestinal symptoms."
        ]
    },
    "structured_content": {
        "Qin Yan Gao Ying Xuan Chen Jing Yuan Fang": [
            "Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",
            "Correspondence Jing Yuan Fang, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Middle Shandong Road, Shanghai",
            "ORCID Qin Yan Gao https://orcid.org/0000-0001-9422-300X Ying Xuan Chen https://orcid.org/0000-0002-1883-7736 Jing Yuan Fang https://orcid.org/0000-0003-2282-0248"
        ],
        "REFERENCES": [
            "1. Wu F, Zhao S, Yu B, et al A new coronavirus associated with human respiratory disease in China [published online ahead of print February 3, 2020]. Nature. https://doi.org/10.1038/s41586-0202008-3.",
            "2. Chen N, Zhou M, Dong X, et al Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223): 507-513.",
            "3. Wang D, Hu B, Hu C, et al Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print February 7, 2020]. JAMA. https://doi.org/10.1001/jama.2020.1585.",
            "4. Zhang W, Du RH, Li B, et al Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):[386-389].",
            "5. Lu R, Zhao X, Li J, et al Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):[565-574].",
            "6. Chai Z, Hu L, Zhang Y, et al Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection [Epub on www.biorxiv.org February 04, 2020]. Available from: https://www.biorxiv.org/content/10.1101/2020.02.03. 931766v1",
            "7. Hashimoto T, Perlot T, Rehman A, et al ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012; 487(7408):[477-481].",
            "8. Bradley KC, Finsterbusch K, Schnepf D, et al Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep. 2019;28(1):245-256.e4.",
            "9. National Health Committee of the People's Republic of China, National Administration of Traditional Chinese Medicine. Diagnostic and therapeutic guidance for 2019 novel coronavirus disease (version 5). Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/ d4b895337e19445f8d728fcaf1e3e13a/files/ ab6bec7f93e64e7f998d802991203cd6.pdf"
        ]
    },
    "participants": [
        {
            "participant": "coronaviruses species",
            "number": 6,
            "context": ". <mark class=\"stats\">Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality</mark>. And COVID-19 is the seventh"
        }
    ],
    "statistics": [],
    "keywords": [
        "coronavirus",
        "mers cov",
        "COVID-19",
        "clinical characteristic",
        "high mortality",
        "Digestive disease",
        "severe acute respiratory syndrome coronavirus",
        "phylogenetic analysis",
        "human infection",
        "complete viral genome",
        "human disease",
        "middle east respiratory syndrome coronavirus",
        "pneumonia",
        "gastrointestinal symptom",
        "angiotensin-converting enzyme 2",
        "severe respiratory illness",
        "novel coronavirus",
        "nucleotides",
        "nucleotide similarity"
    ],
    "keyword_relevance": {
        "COVID-19": 0.2608695652173913,
        "coronavirus": 0.2028985507246377,
        "angiotensin-converting enzyme 2": 0.15942028985507245,
        "novel coronavirus": 0.10144927536231885,
        "gastrointestinal symptom": 0.07246376811594203,
        "pneumonia": 0.057971014492753624,
        "severe acute respiratory syndrome coronavirus": 0.028985507246376812,
        "clinical characteristic": 0.014492753623188406,
        "high mortality": 0.014492753623188406,
        "human infection": 0.014492753623188406,
        "complete viral genome": 0.014492753623188406,
        "human disease": 0.014492753623188406,
        "severe respiratory illness": 0.014492753623188406,
        "nucleotides": 0.014492753623188406,
        "nucleotide similarity": 0.014492753623188406,
        "mers cov": 0.0,
        "Digestive disease": 0.0,
        "phylogenetic analysis": 0.0,
        "middle east respiratory syndrome coronavirus": 0.0
    },
    "species": [],
    "summary": [
        "Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality.",
        "More evidence is needed, Zhang et al[<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>] from the People's Hospital of Wuhan University have reported the presence of viral nucleic acids in the fecal samples and anal swabs of patients with COVID-19.",
        "One study showed by molecular modeling that there is a structural similarity between the receptor-binding domains of SARS-CoV and COVID-19, which means that COVID-19 may use ACE2 as the receptor despite the presence of amino acid mutations in the COVID-19 receptor-binding domain.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>] This finding was subsequently verified by another study which suggested that liver abnormalities might occur in patients with COVID-19 because the cholangiocytes are targeted by these viruses through ACE2.6 ACE2 is known to be abundant in the epithelia of the lungs and intestine in humans, which might enhance the evidence of this possible route for COVID-19.",
        "The authors speculate that COVID-19 may, to some extent, be related to the gut microbiota.",
        "It is well known that the respiratory tract houses its own microbiota, but patients with respiratory infections generally have gut dysfunction or secondary gut dysfunction complications, which are related to a more severe clinical course of the disease, indicating gut\u2013lung crosstalk.",
        "Numerous studies have shown that modulating gut microbiota can reduce enteritis and ventilator-associated pneumonia, and it can reverse certain side effects of antibiotics to avoid early influenza virus replication in lung epithelia.[<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>] Currently, there is no direct clinical evidence that the modulation of gut microbiota plays the therapeutic role in the treatment of COVID-19, but the authors speculate that targeting gut microbiota may be a new therapeutic option or at least an adjuvant therapeutic choice.",
        "In early February, the guidance established by the China's National Health Commission and National Administration of Traditional Chinese Medicine[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] recommended that in the treatment of patients with severe COVID-19 infection, probiotics may be used to maintain the balance of intestinal microecology and prevent secondary bacterial infection, which shows that the Chinese government and first-line medical staffs accept the importance of the role of gut microbiota in COVID-19 infection.",
        "Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",
        "Correspondence Jing Yuan Fang, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Middle Shandong Road, Shanghai"
    ],
    "structured_summary": {
        "Introduction": [
            "Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality.",
            "More evidence is needed, Zhang et al[<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>] from the People's Hospital of Wuhan University have reported the presence of viral nucleic acids in the fecal samples and anal swabs of patients with COVID-19."
        ],
        "Results": [
            "One study showed by molecular modeling that there is a structural similarity between the receptor-binding domains of SARS-CoV and COVID-19, which means that COVID-19 may use ACE2 as the receptor despite the presence of amino acid mutations in the COVID-19 receptor-binding domain.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>] This finding was subsequently verified by another study which suggested that liver abnormalities might occur in patients with COVID-19 because the cholangiocytes are targeted by these viruses through ACE2.6 ACE2 is known to be abundant in the epithelia of the lungs and intestine in humans, which might enhance the evidence of this possible route for COVID-19.",
            "The authors speculate that COVID-19 may, to some extent, be related to the gut microbiota.",
            "It is well known that the respiratory tract houses its own microbiota, but patients with respiratory infections generally have gut dysfunction or secondary gut dysfunction complications, which are related to a more severe clinical course of the disease, indicating gut\u2013lung crosstalk.",
            "Numerous studies have shown that modulating gut microbiota can reduce enteritis and ventilator-associated pneumonia, and it can reverse certain side effects of antibiotics to avoid early influenza virus replication in lung epithelia.[<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>] Currently, there is no direct clinical evidence that the modulation of gut microbiota plays the therapeutic role in the treatment of COVID-19, but the authors speculate that targeting gut microbiota may be a new therapeutic option or at least an adjuvant therapeutic choice.",
            "In early February, the guidance established by the China's National Health Commission and National Administration of Traditional Chinese Medicine[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] recommended that in the treatment of patients with severe COVID-19 infection, probiotics may be used to maintain the balance of intestinal microecology and prevent secondary bacterial infection, which shows that the Chinese government and first-line medical staffs accept the importance of the role of gut microbiota in COVID-19 infection."
        ],
        "Conclusion": [
            "Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China",
            "Correspondence Jing Yuan Fang, Division of Gastroenterology and Hepatology, Key Laboratory of Gastroenterology & Hepatology, Ministry of Health, State Key Laboratory of Oncogene and Related Genes, Shanghai Institute of Digestive Disease, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, 145 Middle Shandong Road, Shanghai"
        ]
    },
    "reference_links": [
        {
            "id": "1",
            "alt_id": "Wu_et+al_2020_a",
            "entry": "1. Wu F, Zhao S, Yu B, et al. A new coronavirus associated with human respiratory disease in China [published online ahead of print February 3, 2020]. Nature. https://doi.org/10.1038/s41586-0202008-3.",
            "crossref": "https://dx.doi.org/10.1038/s41586-0202008-3",
            "scite": "https://scite.ai/reports/10.1038/s41586-0202008-3"
        },
        {
            "id": "2",
            "alt_id": "Chen_et+al_2019_a",
            "entry": "2. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223): 507-513.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Chen%20N%20Zhou%20M%20Dong%20X%20et%20al%20Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan%20China%20a%20descriptive%20study%20Lancet%20202039510223%20507513",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Chen%20N%20Zhou%20M%20Dong%20X%20et%20al%20Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan%20China%20a%20descriptive%20study%20Lancet%20202039510223%20507513",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Chen%20N%20Zhou%20M%20Dong%20X%20et%20al%20Epidemiological%20and%20clinical%20characteristics%20of%2099%20cases%20of%202019%20novel%20coronavirus%20pneumonia%20in%20Wuhan%20China%20a%20descriptive%20study%20Lancet%20202039510223%20507513"
        },
        {
            "id": "3",
            "alt_id": "Wang_et+al_February 7,_a",
            "entry": "3. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China [published online ahead of print February 7, 2020]. JAMA. https://doi.org/10.1001/jama.2020.1585.",
            "crossref": "https://dx.doi.org/10.1001/jama.2020.1585",
            "scite": "https://scite.ai/reports/10.1001/jama.2020.1585",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=https%3A//dx.doi.org/10.1001/jama.2020.1585"
        },
        {
            "id": "4",
            "alt_id": "Zhang_et+al_2019_a",
            "entry": "4. Zhang W, Du RH, Li B, et al. Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes. Emerg Microbes Infect. 2020;9(1):386-389.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Zhang%20W%20Du%20RH%20Li%20B%20et%20al%20Molecular%20and%20serological%20investigation%20of%202019nCoV%20infected%20patients%20implication%20of%20multiple%20shedding%20routes%20Emerg%20Microbes%20Infect%20202091386389",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Zhang%20W%20Du%20RH%20Li%20B%20et%20al%20Molecular%20and%20serological%20investigation%20of%202019nCoV%20infected%20patients%20implication%20of%20multiple%20shedding%20routes%20Emerg%20Microbes%20Infect%20202091386389",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Zhang%20W%20Du%20RH%20Li%20B%20et%20al%20Molecular%20and%20serological%20investigation%20of%202019nCoV%20infected%20patients%20implication%20of%20multiple%20shedding%20routes%20Emerg%20Microbes%20Infect%20202091386389"
        },
        {
            "id": "5",
            "alt_id": "Lu_et+al_2019_a",
            "entry": "5. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-574.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Lu%20R%20Zhao%20X%20Li%20J%20et%20al%20Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus%20implications%20for%20virus%20origins%20and%20receptor%20binding%20Lancet%20202039510224565574",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Lu%20R%20Zhao%20X%20Li%20J%20et%20al%20Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus%20implications%20for%20virus%20origins%20and%20receptor%20binding%20Lancet%20202039510224565574",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Lu%20R%20Zhao%20X%20Li%20J%20et%20al%20Genomic%20characterisation%20and%20epidemiology%20of%202019%20novel%20coronavirus%20implications%20for%20virus%20origins%20and%20receptor%20binding%20Lancet%20202039510224565574"
        },
        {
            "id": "6",
            "alt_id": "Chai_et+al_2019_a",
            "entry": "6. Chai Z, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection [Epub on www.biorxiv.org February 04, 2020]. Available from: https://www.biorxiv.org/content/10.1101/2020.02.03.931766v1",
            "url": "http://www.biorxiv.org"
        },
        {
            "id": "7",
            "alt_id": "Hashimoto_et+al_2012_a",
            "entry": "7. Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012; 487(7408):477-481.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Hashimoto%2C%20T.%20Perlot%2C%20T.%20Rehman%2C%20A.%20ACE2%20links%20amino%20acid%20malnutrition%20to%20microbial%20ecology%20and%20intestinal%20inflammation%202012",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Hashimoto%2C%20T.%20Perlot%2C%20T.%20Rehman%2C%20A.%20ACE2%20links%20amino%20acid%20malnutrition%20to%20microbial%20ecology%20and%20intestinal%20inflammation%202012",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Hashimoto%2C%20T.%20Perlot%2C%20T.%20Rehman%2C%20A.%20ACE2%20links%20amino%20acid%20malnutrition%20to%20microbial%20ecology%20and%20intestinal%20inflammation%202012"
        },
        {
            "id": "8",
            "alt_id": "Bradley_et+al_2019_a",
            "entry": "8. Bradley KC, Finsterbusch K, Schnepf D, et al. Microbiota-driven tonic interferon signals in lung stromal cells protect from influenza virus infection. Cell Rep. 2019;28(1):245-256.e4.",
            "scholar_url": "https://scholar.google.co.uk/scholar?q=Bradley%2C%20K.C.%20Finsterbusch%2C%20K.%20Schnepf%2C%20D.%20Microbiota-driven%20tonic%20interferon%20signals%20in%20lung%20stromal%20cells%20protect%20from%20influenza%20virus%20infection%202019",
            "oa_query": "https://sandbox-api.scholarcy.com/oa_version?query=Bradley%2C%20K.C.%20Finsterbusch%2C%20K.%20Schnepf%2C%20D.%20Microbiota-driven%20tonic%20interferon%20signals%20in%20lung%20stromal%20cells%20protect%20from%20influenza%20virus%20infection%202019",
            "scite": "https://sandbox-api.scholarcy.com/scite_url?query=Bradley%2C%20K.C.%20Finsterbusch%2C%20K.%20Schnepf%2C%20D.%20Microbiota-driven%20tonic%20interferon%20signals%20in%20lung%20stromal%20cells%20protect%20from%20influenza%20virus%20infection%202019"
        },
        {
            "id": "9",
            "alt_id": "9._5)._a",
            "entry": "9. National Health Committee of the People's Republic of China, National Administration of Traditional Chinese Medicine. Diagnostic and therapeutic guidance for 2019 novel coronavirus disease (version 5). Available from: http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf ",
            "url": "http://www.nhc.gov.cn/yzygj/s7653p/202002/d4b895337e19445f8d728fcaf1e3e13a/files/ab6bec7f93e64e7f998d802991203cd6.pdf"
        }
    ],
    "facts": [
        "Middle East respiratory syndrome coronavirus are both zoonotic in origin",
        "the seventh. Phylogenetic analysis of the complete viral genome has shown that the COVID-19 is",
        "related to a group of SARS-like coronaviruses.1 This fact could partly explain the behavior of this novel coronavirus in human infection",
        "This fact could partly explain the behavior of this novel coronavirus in human infection",
        "China have indicated that the main clinical manifestations of COVID-19 are fever",
        "Less common symptoms include the production of sputum",
        "from the People's Hospital of Wuhan University have reported the presence of viral nucleic acids in the fecal samples",
        "One study showed by molecular modeling",
        "which means that COVID-19 may use ACE2 as the receptor",
        "This finding was subsequently verified by another study",
        "which suggested that liver abnormalities might occur in patients",
        "with COVID-19 because the cholangiocytes are targeted by these viruses through ACE2.6 ACE2 is known to be abundant in the epithelia",
        "which might enhance the evidence of this possible route for COVID-19",
        "Numerous studies have shown that modulating gut microbiota can reduce enteritis",
        "no direct clinical evidence that the modulation of gut microbiota plays the therapeutic role in the treatment",
        "the guidance established by the China's National Health Commission",
        "probiotics may be used to maintain the balance of intestinal microecology",
        "which shows that the Chinese government",
        "first-line medical staffs accept the importance of the role of gut microbiota"
    ],
    "claims": [],
    "findings": [],
    "processes": [],
    "key_statements": [
        "Retrospective studies from Wuhan, China have indicated that the main clinical manifestations of COVID-19 are fever, cough and dyspnea",
        "Less common symptoms include the production of sputum, headache, hemoptysis and some gastrointestinal symptoms",
        "More evidence is needed, Zhang et al[<a class=\"ref-link\" id=\"c4\" href=\"#r4\">4</a>] from the People's Hospital of Wuhan University have reported the presence of viral nucleic acids in the fecal samples and anal swabs of patients with COVID-19",
        "One study showed by molecular modeling that there is a structural similarity between the receptor-binding domains of SARS-CoV and COVID-19, which means that COVID-19 may use angiotensin-converting enzyme 2 as the receptor despite the presence of amino acid mutations in the COVID-19 receptor-binding domain.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]",
        "This finding was subsequently verified by another study which suggested that liver abnormalities might occur in patients with COVID-19 because the cholangiocytes are targeted by these viruses through angiotensin-converting enzyme 2.6 angiotensin-converting enzyme 2 is known to be abundant in the epithelia of the lungs and intestine in humans, which might enhance the evidence of this possible route for COVID-19",
        "Numerous studies have shown that modulating gut microbiota can reduce enteritis and ventilator-associated pneumonia, and it can reverse certain side effects of antibiotics to avoid early influenza virus replication in lung epithelia.[<a class=\"ref-link\" id=\"c8\" href=\"#r8\">8</a>]",
        "There is no direct clinical evidence that the modulation of gut microbiota plays the therapeutic role in the treatment of COVID-19, but we speculate that targeting gut microbiota may be a new therapeutic option or at least an adjuvant therapeutic choice",
        "In early February, the guidance established by the China's National Health Commission and National Administration of Traditional Chinese Medicine[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] recommended that in the treatment of patients with severe COVID-19 infection, probiotics may be used to maintain the balance of intestinal microecology and prevent secondary bacterial infection, which shows that the Chinese government and first-line medical staffs accept the importance of the role of gut microbiota in COVID-19 infection"
    ],
    "top_statements": [
        "Six coronaviruses species are known to cause human diseases, among them severe acute respiratory syndrome coronavirus (SARSCoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) are both zoonotic in origin, which can cause severe respiratory illness and high mortality",
        "Retrospective studies from Wuhan, China have indicated that the main clinical manifestations of COVID-19 are fever, cough and dyspnea",
        "Less common symptoms include the production of sputum, headache, hemoptysis and some gastrointestinal symptoms",
        "One study showed by molecular modeling that there is a structural similarity between the receptor-binding domains of SARS-CoV and COVID-19, which means that COVID-19 may use angiotensin-converting enzyme 2 as the receptor despite the presence of amino acid mutations in the COVID-19 receptor-binding domain.[<a class=\"ref-link\" id=\"c5\" href=\"#r5\">5</a>]",
        "This finding was subsequently verified by another study which suggested that liver abnormalities might occur in patients with COVID-19 because the cholangiocytes are targeted by these viruses through angiotensin-converting enzyme 2.6 angiotensin-converting enzyme 2 is known to be abundant in the epithelia of the lungs and intestine in humans, which might enhance the evidence of this possible route for COVID-19",
        "In early February, the guidance established by the China's National Health Commission and National Administration of Traditional Chinese Medicine[<a class=\"ref-link\" id=\"c9\" href=\"#r9\">9</a>] recommended that in the treatment of patients with severe COVID-19 infection, probiotics may be used to maintain the balance of intestinal microecology and prevent secondary bacterial infection, which shows that the Chinese government and first-line medical staffs accept the importance of the role of gut microbiota in COVID-19 infection"
    ],
    "headline": "This finding was subsequently verified by another study which suggested that liver abnormalities might occur in patients with COVID-19 because the cholangiocytes are targeted by these viruses through angiotensin-converting enzyme 2.6 angiotensin-converting enzyme 2 is known to be abundant in the epithelia of the lungs and intestine in humans, which might enhance the evidence of this possible route for COVID-19",
    "contexts": [],
    "abbreviations": {
        "SARSCoV": "severe acute respiratory syndrome coronavirus",
        "ACE2": "angiotensin-converting enzyme 2"
    }
}
